{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T12:03:22Z","timestamp":1780056202792,"version":"3.54.0"},"reference-count":43,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2015,5,4]],"date-time":"2015-05-04T00:00:00Z","timestamp":1430697600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J of Rheum Dis"],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aim<\/jats:title><jats:p>To compare the diagnostic performance of rheumatoid factor (<jats:styled-content style=\"fixed-case\">RF<\/jats:styled-content>) and anti\u2010cyclic citrullinated peptide antibody (anti\u2010<jats:styled-content style=\"fixed-case\">CCP<\/jats:styled-content>) in the diagnosis of patients with rheumatoid arthritis (<jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content>) in Taiwan.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Serum concentrations of <jats:styled-content style=\"fixed-case\">RF<\/jats:styled-content> and anti\u2010<jats:styled-content style=\"fixed-case\">CCP<\/jats:styled-content> were measured in 246 cases, including 39 patients with <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content> and 207 patients with other rheumatic diseases (non\u2010<jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content>). The age, sex, clinical presentation, <jats:styled-content style=\"fixed-case\">RF<\/jats:styled-content>, anti\u2010<jats:styled-content style=\"fixed-case\">CCP<\/jats:styled-content> results and the final diagnoses were recorded and analyzed. The sensitivity, specificity, positive predictive value (<jats:styled-content style=\"fixed-case\">PPV<\/jats:styled-content>), negative predictive value (<jats:styled-content style=\"fixed-case\">NPV<\/jats:styled-content>), positive likelihood ratio (<jats:styled-content style=\"fixed-case\">LR<\/jats:styled-content>+) and negative likelihood ratio (<jats:styled-content style=\"fixed-case\">LR<\/jats:styled-content>\u2212) were calculated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among all 246 patients, 39 (15.9%) were diagnosed with <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content> and 207 (84.1%) were diagnosed with other rheumatic diseases (non\u2010<jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content>). In the diagnosis of <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content>, the sensitivity, specificity, <jats:styled-content style=\"fixed-case\">PPV<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\"> NPV<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\"> LR<\/jats:styled-content>+ and <jats:styled-content style=\"fixed-case\">LR<\/jats:styled-content>\u2212 of the <jats:styled-content style=\"fixed-case\">RF<\/jats:styled-content> test were 67%, 79%, 37%, 93%, 3.12, and 0.42, respectively. The corresponding data for the anti\u2010<jats:styled-content style=\"fixed-case\">CCP<\/jats:styled-content> test were 79%, 98%, 86%, 96%, 32.91 and 0.21, respectively. The presence of either anti\u2010<jats:styled-content style=\"fixed-case\">CCP<\/jats:styled-content> or <jats:styled-content style=\"fixed-case\">RF<\/jats:styled-content> increased the sensitivity to 85%, and when they both were present, the specificity increased to 98%. Among the 39 <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content> patients, 26 (66.7%) tested positive for <jats:styled-content style=\"fixed-case\">RF<\/jats:styled-content>, and 31 (79.5%) tested positive for anti\u2010<jats:styled-content style=\"fixed-case\">CCP<\/jats:styled-content>. <jats:styled-content style=\"fixed-case\">RF<\/jats:styled-content> was positive in two of eight anti\u2010<jats:styled-content style=\"fixed-case\">CCP<\/jats:styled-content>\u2010negative patients with <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content>, and anti\u2010<jats:styled-content style=\"fixed-case\">CCP<\/jats:styled-content> was positive in seven of 13 <jats:styled-content style=\"fixed-case\">RF<\/jats:styled-content>\u2010negative patients with <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The <jats:styled-content style=\"fixed-case\">RF<\/jats:styled-content> and anti\u2010<jats:styled-content style=\"fixed-case\">CCP<\/jats:styled-content> tests are complementary, and the co\u2010detection of these antibodies can increase the detection rate and provide important clinical value in the diagnosis of <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content>. Both anti\u2010<jats:styled-content style=\"fixed-case\">CCP<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">RF<\/jats:styled-content> positivity are useful for the diagnosis of <jats:styled-content style=\"fixed-case\">RA<\/jats:styled-content>, and use of both tests together improves the diagnostic sensitivity.<\/jats:p><\/jats:sec>","DOI":"10.1111\/1756-185x.12552","type":"journal-article","created":{"date-parts":[[2015,5,4]],"date-time":"2015-05-04T14:15:36Z","timestamp":1430748936000},"page":"880-886","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Diagnostic performance of anti\u2010cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis"],"prefix":"10.1111","volume":"19","author":[{"given":"Pi\u2010Yueh","family":"Chang","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine Chang\u2010Gung Memorial Hospital Tao\u2010Yuan Taiwan"},{"name":"Department of Medical Biotechnology and Laboratory Science Tao\u2010Yuan Taiwan"},{"name":"Chang Gung University Tao\u2010Yuan Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng\u2010Tao","family":"Yang","sequence":"additional","affiliation":[{"name":"Division of Chinese Medicine Chang\u2010Gung Memorial Hospital and Chang Gung University Tao\u2010Yuan Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching\u2010Hui","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine Chang\u2010Gung Memorial Hospital Tao\u2010Yuan Taiwan"},{"name":"Department of Medical Biotechnology and Laboratory Science Tao\u2010Yuan Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuang\u2010Hui","family":"Yu","sequence":"additional","affiliation":[{"name":"Chang Gung University Tao\u2010Yuan Taiwan"},{"name":"Division of Rheumatology, Allergy and Immunology Department of Internal Medicine Chang Gung Memorial Hospital and Chang\u2010Gung University Tao\u2010Yuan Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,5,4]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2013.111"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21820"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.2174\/1573397052954217"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-0172(99)80003-1"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-857X(21)00886-3"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar395"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202628"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60826-4"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar551"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.014233"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-011-2153-y"},{"key":"e_1_2_7_13_1","first-page":"11","article-title":"Diagnostic accuracy of combined tests of anti\u2010cyclic citrullinated peptide\u00a0antibody and rheumatoid factor for rheumatoid arthritis: a meta\u2010analysis","volume":"32","author":"Sun J","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-11-200706050-00008"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/47.6.1089"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.9.870"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310302"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.27584"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.051391"},{"key":"e_1_2_7_21_1","first-page":"711","article-title":"Diagnostic utility of anti\u2010citrullinated protein antibody and its comparison with rheumatoid factor in rheumatoid arthritis","volume":"22","author":"Khan AH","year":"2012","journal-title":"J Coll Physicians Surg Pak"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.318.7194.1322"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.12129"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-007-0601-6"},{"key":"e_1_2_7_25_1","first-page":"2390","article-title":"Diagnostic utility of anti\u2010cyclic citrullinated peptide antibodies for very early rheumatoid arthritis","volume":"33","author":"Matsui T","year":"2006","journal-title":"J Rheumatol"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.11223"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780270805"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.23.4.302"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1443.013"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2014.01.006"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kei111"},{"key":"e_1_2_7_32_1","first-page":"1393","article-title":"Anti\u2010cyclic citrullinated peptide antibody: an early diagnostic and prognostic biomarker of rheumatoid arthritis","volume":"6","author":"Manivelavan D","year":"2012","journal-title":"J Clin Diagn Res"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/03009740310003677"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2013-0798"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/815038"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1080\/03009740510026706"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2005.20.3.473"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-009-1058-5"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1080\/03009740510026634"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1313.033"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2420"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-010-1374-x"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-012-2572-4"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.016808"}],"container-title":["International Journal of Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2F1756-185X.12552","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1756-185X.12552","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T14:30:02Z","timestamp":1724769002000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1756-185X.12552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,4]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["10.1111\/1756-185X.12552"],"URL":"https:\/\/doi.org\/10.1111\/1756-185x.12552","archive":["Portico"],"relation":{},"ISSN":["1756-1841","1756-185X"],"issn-type":[{"value":"1756-1841","type":"print"},{"value":"1756-185X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,4]]},"assertion":[{"value":"2015-05-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}